Layout Table~~~~2626~2626~~

Theranostics Report 2007-2012~
Published by Visiongain, January 2007

Key questions remain over theranostics. How can your company secure key successes and ideals in personalized medicine - aiming the right drug at the right person and at the right time. Plus with increased FDA regulation, how can we guarantee that that specific drug is safe for that individual. These issues are not going away, but one report can make it a lot easier for you and your company.

This report delivers to you a clear understanding of the commercial prospects of theranostics. The fusion of drug therapy and diagnostics, with the purpose of optimising efficacy and safety, as well as streamlining the process of drug development offers you and your company clear opportunities. This emerging field is generating interest from the healthcare industry and regulatory bodies, with the associated market expanding continually as the importance of theranostics is recognised.

~
Published by Visiongain, January 2007

Key questions remain over theranostics. How can your company secure key successes and ideals in personalized medicine - aiming the right drug at the right person and at the right time. Plus with increased FDA regulation, how can we guarantee that that specific drug is safe for that individual. These issues are not going away, but one report can make it a lot easier for you and your company.

This report delivers to you a clear understanding of the commercial prospects of theranostics. The fusion of drug therapy and diagnostics, with the purpose of optimising efficacy and safety, as well as streamlining the process of drug development offers you and your company clear opportunities. This emerging field is generating interest from the healthcare industry and regulatory bodies, with the associated market expanding continually as the importance of theranostics is recognised.

Theranostic solutions are playing an increasingly important role in pharmaceutical R&D - increasing safety, speeding up clinical development and facilitating regulatory acceptance. Furthermore, theranostics is paving the way towards the long-held goal of personalised medicine, to the benefit of patients and payers. Theranostics has also received encouraging support from regulators such as the FDA. Pharmaceutical, diagnostics and biotechnological companies cannot afford to overlook this rapidly emerging field. So you should be sure you corner your percentage of the market immediately.

Theranostics 2007-2012 examines the market for theranostic solutions critically, through comprehensive primary and secondary research. Importantly, visiongain discusses theranostics in the context of the wider diagnostics market. In addition to consultation with experts in industry, this research involved a detailed study of documents, industrial reports and relevant news. Importantly, visiongain also applied techniques such as financial forecasting and SWOT analyses. The result is a comprehensive market-based report with detailed analysis and informed opinion.

In particular, this report concentrates on the following essential aspects of the theranostics sector:

Technologies that drive the theranostics sector
Key industrial players in theranostics - including partnerships in that field Forecasts of the global theranostics market from 2007-2012, including forecasts of the molecular diagnostics market and principal market segments within theranostics Drivers and opportunities in the theranostics sector Restraints and threats in the theranostics sector Assessments of relevant business models, technological solutions and associated issues Coverage of future trends in the sector Insight from a survey with experts from industry and academia

Why you should buy this report:

To receive a comprehensive analysis of the prospects for theranostics from 2007-2012 To discover predicted revenues, growth rates and other key metrics for theranostic solutions from 2006-2011 To receive the views of experts in the theranostics sector To determine the forces that influence the market for theranostics: Competitive characteristics of the market, Drivers, Restraints, Strengths, weaknesses, opportunities and threats

To find out where theranostics is heading - both technologically and commercially Visiongain predicts that all aspects of theranostics will exhibit strong growth in revenues from 2007-2012, with significant investments being made by far-sighted companies in the pharmaceutical, diagnostics and biotechnological sectors. Although still in its early stages of commercial development, theranostics will increasingly gain acceptance from stakeholders in healthcare. Successful participating companies will benefit as a result, gaining early market prominence from high-value products. But which areas of theranostics will that be? Find out today by ordering your executive copy of Theranostics 2007.

Table of Contents | Sample Pages
~Theranostics Report 2007-2012 (Single User License)|781|Theranostics Report 2007-2012 (Departmental License)|782|Theranostics Report 2007-2012 (Company Wide License)|783|~2626~2633~~

Molecular Diagnostics~
Published by Select Biosciences, Spring 2005

The molecular diagnostics marketplace offers a growth opportunity given the interest in utilizing molecular tools to precisely target therapeutics.

This report analyzes the technologies and their impact in the molecular diagnostics marketplace. An assessment of all the technologies of value in this market and which market segments are impacted and affected by these technologies.

Furthermore, in this report are presented qualitative and quantitative market analysis of molecular diagnostics. Presented are total industry revenues, growth rates, and the various qualitative drivers that are contributing to the growth of the marketplace.
~Published by Select Biosciences, Spring 2005

The molecular diagnostics marketplace offers a growth opportunity given the interest in utilizing molecular tools to precisely target therapeutics.

This report analyzes the technologies and their impact in the molecular diagnostics marketplace. An assessment of all the technologies of value in this market and which market segments are impacted and affected by these technologies.

Furthermore, in this report are presented qualitative and quantitative market analysis of molecular diagnostics. Presented are total industry revenues, growth rates, and the various qualitative drivers that are contributing to the growth of the marketplace.

Key Highlights of this Report:

• Qualitative and quantitative market analyses, and market forecasts
• Technology assessment and competitive analysis
• All the major technology platforms deployed in molecular diagnostics:
    o Instrumentation
    o Complete Assay Technologies
• Approval processes for molecular diagnostics for US, European Union, and Japan are presented. This is key information for new entrants into this marketplace.
• Segments of the molecular diagnostics marketplace
• Qualitative market drivers
• Quantitative Market Analysis
    o Total market size in terms of industry revenues and growth rate
    o Emerging market segments-and estimated market sizes
    o Growth areas in terms of classes of analytes-biological targets for development of molecular diagnostics

Companies mentioned in the report

A&G Pharmaceutical
Abbott Laboratories
Affymetrix
Amorfix Life Sciences
AstraZeneca
Axis-Shield
Bayer
Biogen Idec
Bristol-Myers Squibb
Cambridge Theranostics
Chiron
Clinical Data
CyGene
DakoCytomation
Digene
DNAPrint Genomics
Epigenomics
EXACT Sciences
Fornix Theranostics
Gemini (Eurona)
Genaissance Pharmaceuticals
Genentech
Genetic Vectors
Gen-Probe
Glaxo Wellcome
HBV Theranostica
Hyseq
IGEN International
ImClone Systems
Innogenetics
Investigen
Itsi-Biosciences
Kingo Diagnostika
Lpath Therapeutics
Merck & CO.
Millennium Predictive Medicine
Myriad Genetics
Neighborhood Connections
NGI
Novartis
Oncogene Science
Organon Teknika
PeptiFarma
PGxHealth
PharmaNetics
Pronto Diagnostics
Provalis
Quidel
Roche
Seapro Theranostics International B.V
Sequenom
The Boston Consulting Group
TheraNostics GmbH
Tibotec-Virco
Ventana Medical Systems
Visible Genetics
Vysis
Wyeth


Table of contents | Sample Pages ~Molecular Diagnostics (single user print version)|757|Molecular Diagnostics (Eletronic site license PDF + One print Copy)|758|~2626~2632~~